Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

BC Cancer Agency

InstitutionResearch output, impact & collaborations

BC Cancer Agency is a research organisation in Vancouver, CA. OpenAlex records 17,005 works and 4,535,830 citations for it. 2,553 researchers list it as their most recent affiliation.

17,005
Works
4,535,830
Citations
2,553
Researchers
63.3
Avg h-index

How has BC Cancer Agency's publication output changed over time?

ScholarIQpublication output · 2004–2020

Output grew100% over the shown period — from 1 works in 2004 to 2 in 2020.

1
1
1
1
2
1
1
2
2
200420052010201120122013201520182020

Who are the most-cited researchers behind BC Cancer Agency?

ScholarIQtop researchers by citations
1
Kim N. · Prostate Cancer Treatment and Research
853 works52,262 citations
2
Caroline Lohrisch · Breast Cancer Treatment Studies
171 works9,533 citations
3
Mohammad Atiquzzaman · COVID-19 Clinical Research Studies
47 works604 citations
4
Jonathan Avery · Palliative Care and End-of-Life Issues
79 works553 citations
5
Dilshani Induruwage · Renal Diseases and Glomerulopathies
17 works197 citations

What are the most-cited papers on BC Cancer Agency?

ScholarIQmost cited works
Signatures of mutational processes in human cancer
Australian Pancreatic Cancer Genome Initiative, Ludmil B. Alexandrov, ICGC PedBrain, Serena Nik‐Zainal, David C. Wedge, Samuel Aparício, Sam Behjati, Andrew V. Biankin, Graham R. Bignell, Niccolò Bolli, Åke Borg, Anne‐Lise Børresen‐Dale, Sandrine Boyault, Birgit Burkhardt, Adam P. Butler, Carlos Caldas, Helen Davies, Christine Desmedt, Roland Eils, Jórunn E. Eyfjörd, John A. Foekens, Mel Greaves, Fumie Hosoda, Barbara Hutter, Tomislav Ilicic, Sandrine Imbeaud, Marcin Imieliński, Natalie Jäger, David Jones, David R. Jones, Stian Knappskog, Marcel Kool, Sunil R. Lakhani, Carlos López-Otı́n, Sancha Martin, Nikhil C. Munshi, Hiromi Nakamura, Paul A. Northcott, Marina Pajic, Elli Papaemmanuil, Angelo Paradiso, John V. Pearson, Xosé S. Puente, Keiran Raine, Manasa Ramakrishna, Andrea L. Richardson, Julia Richter, Philip Rosenstiel, Matthias Schlesner, Ton N. Schumacher, Paul N. Span, Jon W. Teague, Yasushi Totoki, Andrew Tutt, Rafael Valdés‐Mas, Marit M. van Buuren, Laura van ‘t Veer, Anne Vincent‐Salomon, Nicola Waddell, Lucy Yates, Jessica Zucman‐Rossi, P. Andrew Futreal, Ultan McDermott, Peter Lichter, Matthew Meyerson, Sean M. Grimmond, Reiner Siebert, Elı́as Campo, Tatsuhiro Shibata, Stefan M. Pfister, Peter J. Campbell, Michael R. Stratton
Nature. 201310,238 CitationsOPEN ACCESS
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Christina Curtis, Sohrab P. Shah, Suet‐Feung Chin, Gulisa Turashvili, Oscar M. Rueda, Mark Dunning, Doug Speed, Andy G. Lynch, Shamith Samarajiwa, Yinyin Yuan, Stefan Gräf, Gavin Ha, Gholamreza Haffari, Ali Bashashati, Roslin Russell, Steven McKinney, Anita Langerød, Andrew R. Green, Elena Provenzano, Gordon Wishart, Sarah E. Pinder, Peter H. Watson, Florian Markowetz, Leigh C. Murphy, Ian O. Ellis, Arnie Purushotham, Anne‐Lise Børresen‐Dale, James D. Brenton, Simon Tavaré, Carlos Caldas, Samuel Aparício
Nature. 20126,440 CitationsOPEN ACCESS
Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
Claudia Allemani, Tomohiro Matsuda, V Di Carlo, Rhea Harewood, M Matz, Maja Nikšić, Audrey Bonaventure, М. Yu. Valkov, Christopher J. Johnson, Jacques Estève, Olufemi J. Ogunbiyi, Gulnar Azevedo e Silva, Wanqing Chen, Sultan Eser, Gerda Engholm, Charles Stiller, Alain Monnereau, Ryan Woods, Otto Visser, Gek Hsiang Lim, Joanne F. Aitken, Hannah K. Weir, Michel P. Coleman, S. Bouzbid, M Hamdi-Chérif, Zoubida Zaidi, Kaouel Meguenni, D. Regagba, Siné Bayo, T Cheick Bougadari, S S Manraj, Karima Bendahhou, A. Fabowale, Debbie Bradshaw, Nontuthuzelo Somdyala, I. Kumcher, Florencia Moreno, G.H. Calabrano, S.B. Espinola, B Carballo Quintero, R Fita, M C Diumenjo, W.D. Laspada, S.G. Ibañez, Carlos Anselmo Lima, P.C.F. De Souza, K Del Pino, C. Laporte, María Paula Curado, José Carlos de Oliveira, C.L.A. Veneziano, Donaldo Botelho Veneziano, M R D O Latorre, Luana Fiengo Tanaka, Marise Souto Rebelo, M O Santos, J.C. Galaz, M Aparicio Aravena, J Sanhueza Monsalve, D.A. Herrmann, S Torres Vargas, Víctor Herrera, Claudia Uribe, Luis Eduardo Bravo, Luz Stella García, Nelson Enrique Arias-Ortiz, D Morantes, Daniel Jurado, María Clara Yépez Chamorro, Sandra Delgado, Melissa Ramirez, Y H Galán Alvarez, Priscila Torres, F Martínez-Reyes, L. Jaramillo, R. Quinto, J Castillo, M Mendoza, Patricia Cueva, J.G. Yépez, Bernard Bhakkan, Jacqueline Deloumeaux, Clarisse Joachim, Jonathan Macni, R Carrillo, J Shalkow Klincovstein, Rebeca Rivera-Gómez, Ebert Poquioma, Guillermo Tortolero‐Luna, Diego Zavala, R. Alonso, Enrique Barrios, Angela Eckstrand, C Nikiforuk, Glen Noonan, Donna Turner, Eshwar Kumar, B Zhang, F.R. McCrate, S. Ryan
The Lancet. 20186,234 CitationsOPEN ACCESS
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Robert J. Motzer, Bernard Escudier, Ray McDermott, Saby George, Hans J. Hammers, Sandhya Srinivas, Scott S. Tykodi, Jeffrey A. Sosman, Giuseppe Procopio, Elizabeth R. Plimack, Daniel Castellano, Toni K. Choueiri, Howard Gurney, Frede Donskov, Petri Bono, John Wagstaff, Thomas Gauler, Takeshi Ueda, Yoshihiko Tomita, Fabio A.B. Schutz, Christian Kollmannsberger, James Larkin, Alain Ravaud, Jason S. Simon, Li-An Xu, Ian M. Waxman, Padmanee Sharma
New England Journal of Medicine. 20155,921 CitationsOPEN ACCESS
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
Ian F. Tannock, Ronald de Wit, William R. Berry, J Horti, A Płużańska, Kim N., Stéphane Oudard, Christine Théodore, Nicholas D. James, Ingela Turesson, Mark Rosenthal, Mario A. Eisenberger
New England Journal of Medicine. 20045,744 Citations

How much of the research on BC Cancer Agency is open access?

ScholarIQopen access share
92%OPEN ACCESS
Gold
0%
Green
17%
Hybrid
17%
Bronze
58%
Closed
8%

Related on ScholarIQ

Lymphoma Diagnosis and Treatment
Top Topic
Prostate Cancer Treatment and Research
Top Topic
Cancer Genomics and Diagnostics
Top Topic
Advanced Radiotherapy Techniques
Top Topic
Breast Cancer Treatment Studies
Top Topic
Lung Cancer Treatments and Mutations
Top Topic
470M+ articles · free account